Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Olivier Pourquie
University of Nebraska Lincoln, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Anagenesis Biotechnologies
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research proposes to engineer nanofibrous scaffolds coated by biomimetic hydrogels containing culture of induced pluripotent stem cells derived myogenic precursor cells (iPS‐MPCs), which are expected to differentiate into highly organized myotubes. The company is
focused on stem cell‐based therapies for genetic and age‐related muscle degenerative diseases. The research uses the company’s myogenic differentiation protocol to differentiate human iPS cells to skeletal myogenic lineage. If successful, this will be “a paradigm shift in engineering muscle tissues” and could increase interest in the company’s differentiation protocol.
Microengineered scaffolds carrying patient-specific cells and growth factors for treatment of volumetric muscle loss
PROJECT NARRATIVE Traumatic and non-traumatic musculoskeletal disorders are responsible for substantial morbidity, pain and disability, affecting athletes, soldiers, active working people and elder population. Indeed, natural healing and surgical procedures are inefficient in restoring functionality of injured muscles, resulting in a poor quality of life. Here, we plan to engineer nanofibrous scaffolds coated by biomimetic hydrogels containing patient-specific growth factors and cells for engineering implantable muscle tissues.
Filed on December 10, 2018.
Tell us what you know about Olivier Pourquie's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Olivier Pourquie”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Olivier Pourquie | University of Nebraska Lincoln | Conflict of Interest | Anagenesis Biotechnologies | $20,000 - $39,999 |
| Olivier Pourquie | Brigham and Women's Hospital | Conflict of Interest | Anagenesis Biotechnologies | Value cannot be readily determined |
| Olivier Pourquie | University of Nebraska Lincoln | Conflict of Interest | Anagenesis Biotechnologies | Value cannot be readily determined |
| Olivier Pourquie | Brigham and Women's Hospital | Conflict of Interest | Anagenesis Biotechnologies | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.